145 related articles for article (PubMed ID: 35765231)
21. DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study.
Xiao X; Shi L; Li H; Song Y; Liu W; Zhou Z
Oral Oncol; 2015 Jan; 51(1):59-63. PubMed ID: 25459158
[TBL] [Abstract][Full Text] [Related]
22. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
23. Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis.
Paglioni MP; Khurram SA; Ruiz BII; Lauby-Secretan B; Normando AG; Ribeiro ACP; Brandão TB; Palmier NR; Lopes MA; da Silva Guerra EN; Meleti M; Migliorati CA; Carvalho AL; de Matos LL; Kowalski LP; Santos-Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):573-587. PubMed ID: 36153299
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
25. Validity of nomograms for predicting cancer risk in oral leukoplakia and oral lichen planus.
Adeoye J; Su YX
Oral Dis; 2023 Nov; ():. PubMed ID: 38009867
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
28. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
30. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
31. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
32. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
33. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
34. Oral leukoplakia diagnosis and treatment in Europe and Australia: Oral Medicine Practitioners' attitudes and practice.
Pentenero M; Sutera S; Lodi G; Bagan JV; Farah CS
Oral Dis; 2023 Nov; 29(8):3214-3222. PubMed ID: 35792047
[TBL] [Abstract][Full Text] [Related]
35. Malignant transformation rate of oral leukoplakia in an Australian population.
Shearston K; Fateh B; Tai S; Hove D; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563
[TBL] [Abstract][Full Text] [Related]
36. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
38. A modified classification and staging system for oral leukoplakia.
van der Waal I; Schepman KP; van der Meij EH
Oral Oncol; 2000 May; 36(3):264-6. PubMed ID: 10793328
[TBL] [Abstract][Full Text] [Related]
39. C-kit Expression in Oral Leukoplakia.
Tegginamani AS; Shivakumar VH; Ismail SMB; Abraham MT; Fernandes BA; Zamzuri ATB
J Coll Physicians Surg Pak; 2022 Feb; 32(2):256-258. PubMed ID: 35108805
[TBL] [Abstract][Full Text] [Related]
40. Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia.
Chen H; Pei M; Shin SW; Moon S; Nam W; Zheng Z
Anticancer Res; 2023 Nov; 43(11):4937-4946. PubMed ID: 37909982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
